Skip to main content
. 2022 Mar 19;16(9):1447–1460. doi: 10.1093/ecco-jcc/jjac047

Table 1.

CPa9-HNE ELISA parameters.

Species possibilities Human
ELISA range [ng/ml] LLMR-ULMR 9–493 ng/mL [adjusted: 36.3–1970 ng/mL]
IC50 [mean, ng/ml] 78.34
Slope [mean] 0.94
Intra-ELISA mean CV%, QC 9% [5.2-15%]
Inter-ELISA mean CV%, QC 4.3% [1.5-9.3%]
Analyte recovery [%], 24 h, 4°C/20°C 91%/95%
Analyte recovery [%], 48 h, 4°C/20°C 114%/138%
Sample recovery [%], freeze/thaw cycles, 3F/T cycles/4F/T cycles 93%/91%
Dilution recovery [%], serum [MRD = 1:4] 96%
Dilution recovery [%], EDTA [MRD = 1:0] 92%
Spiking recovery [%], serum 101%
Spiking recovery [%], EDTA 99%
Interference, biotin recovery [%] [low/high] 98%/95%
Interference, lipaemia recovery [%] [low/high] 100%/97%
Interference, haemoglobin [%] recovery [low/high] 91%/72%

Percentages are reported as mean.

ELISA, enzyme-linked immunosorbent assay; EDTA, ethylene diamine tetraacetic acid; FT, freeze/thaw; LLMR, lower limit of measurement range; ULMR, upper limit of measurement range; IC50, 50% inhibitory concentration; CV%, coefficient of variance %; QC, quality control samples; MRD, maximum [or minimum] recovery diluent.